USP Pharmaceutical Analytical Impurities

(11beta,17-Dihydroxypregn-4-ene-3,20-dione)

((S)-2-(6-Hydroxynaphthalen-2-yl)propanoic acid)

(2-Hydroxy-3-[2-[4-[(2-pyridinylamino)sulfonyl]phenyl]diazenyl]benzoic acid)

(2-Hydroxy-5-[2-[4-(2-iminopyridin-1(2H)-yl)phenyl]diazenyl]benzoic acid)

((3RS)-6,8-dibromo-3-cyclohexyl-3-methyl-1,2,3,4-tetrahydroquinazolin-3-ium iodide)

((2S,3R,4R,5S,6R)-2-[4-Chloro-3-(4-ethoxy-3-ethylbenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol)

(4,4'-[Oxybis(4,1-phenylenesulfonyl)]dianiline)

(2-[(4-Aminophenyl)sulfonyl]aniline)

(9-Bromo-11beta-hydroxy-16beta-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropionate)

(6alpha-Bromo-9-chloro-11beta-hydroxy-16beta-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropionate)

(9-Chloro-16beta-methyl-3,20-dioxopregna-1,4-diene-11beta,17,21-triyl tripropionate)

(2-{[4-Amino-5-(ethylsulfonyl)-2-methoxybenzamido]methyl}-1-ethylpyrrolidine 1-oxide)

(2-(tert-Butylamino)-1-(2-chlorophenyl)propan-1-one hydrochloride)

(N-1-Dimethyl-4-(methylamino)-1H-imidazole-5-carboxamide hydrochloride)

(21-Hydroxypregna-1,4,9(11),16-tetraene-3,20-dione)

(7-Chloro-1,6,7,8-tetradeoxy-6-[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carboxamido]-1-methylsulfinyl-L-threo-alpha-D-galacto-octopyranose 2-palmitate hydrochloride)

(6beta,9-Difluoro-11beta,21-dihydroxy-16alpha,17-(1-methylethylidenedioxy)pregna-1,4-diene-3,20-dione)

(17-Hydroxy-3,20-dioxopregn-4-ene-11beta,21-diyl diacetate)

(11beta,21-Dihydroxy-3,6,20-trioxopregna-4-en-17-yl pentanoate)

(4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodobenzoic acid)

(4-(4-Ethyl-2,6-diiodophenoxy)-2,6-diiodo-phenol)

(2-[4-(3,5-Diiodo-4-methoxyphenoxy)-3,5-diiodophenyl]ethanamine)

(N-Acetyl-O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine)

(4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodo-benzenemethanol)